%0 Journal Article %A Yanan Long %A Qi Chen %A Henrik Larsson %A Andrey Rzhetsky %T Human Sex Ratio at Birth: Mythical and Observable Trends %D 2020 %R 10.1101/2020.04.09.20058537 %J medRxiv %P 2020.04.09.20058537 %X The human sex ratio at birth (SRB) is defined as the ratio between the number of newborn boys to the total number of newborns per time unit. It is, typically, slightly greater than (more boys than girls) and fluctuates over time. In this study, we sought to “myth-check” previously reported associations (and test new hypotheses) using variants of mixed-effect regression analyses and time-series models on two very large electronic health record datasets, representing the populations in the United States and Sweden, respectively. Our results revealed that neither dataset supported models in which the SRB changed seasonally or in response to variations in ambient temperature, and that an increased level of a diverse array of pollutants were associated with lower SRBs. Moreover, we found that increased levels of industrial and agricultural activity, which served as proxies for water pollution, were also associated with lower SRBs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the DARPA Big Mechanism program under ARO contract W911NF1410333, by National Institutes of Health grants R01HL122712, 1P50MH094267, and U01HL108634-01, and by a gift from Liz and Kent Dauten.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIBM MarketScan databases are available to government, academic and private researchers. Use of the data is contingent upon completing a data use agreement. https://www.ibm.com/us-en/marketplace/marketscan-research-databases %U https://www.medrxiv.org/content/medrxiv/early/2020/04/15/2020.04.09.20058537.full.pdf